Raymond James Financial
TYRA icon

Raymond James Financial’s Tyra Biosciences TYRA Stock Holding History

Raymond James Financial’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.46M Buy
247,098
+77,066
+45% +$2.49M ﹤0.01% 2073
2025
Q4 		$4.47M Buy
170,032
+43,658
+35% +$802K ﹤0.01% 2609
2025
Q3 		$1.77M Buy
126,374
+63,187
+100% +$720K ﹤0.01% 3259
2025
Q2 		$605K Buy
63,187
+8,843
+16% +$84K ﹤0.01% 3891
2025
Q1 		$505K Sell
54,344
-439
-0.8% -$5.68K ﹤0.01% 3936
2024
Q4 		$761K Buy
+54,783
New +$994K ﹤0.01% 3641

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Raymond James Financial's TYRA Position: Q1 2026 in Review

Raymond James Financial increased its Tyra Biosciences (TYRA) stake by 45% in Q1 2026, buying an estimated $2.49M and bringing the position to 247,098 shares worth $9.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2073.

Raymond James Financial first reported a position in TYRA in Q4 2024 and has held it in 6 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Raymond James Financial held 247,098 shares of Tyra Biosciences worth $9.46M as of Q1 2026.
  • Raymond James Financial bought 77,066 Tyra Biosciences shares in Q1 2026, an estimated $2.49M.
  • Tyra Biosciences made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #2073 holding.
  • Raymond James Financial first reported a position in Tyra Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.